What Is the Melting Point of Silica? Values for Quartz, Cristobalite and Fused Silica

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Monodisperse Silica Spheres: Size Control, Synthesis and Applications
  • Keywords: silica supplier
  • Published: 2026-11-20 01:01:28
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
58. Kinnari P., Mäkilä E., Heikkilä T., Salonen J., Hirvonen J., Santos H.A. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int. J. Pharm. 2011;414:148-156. doi: 10.1016/j.ijpharm.2011.05.021. [ DOI ] [ PubMed ] [ Google Scholar ]

Best Silica Supplier: How to Choose in 2026 (Checklist and Comparison Criteria)

Silica for Powder Coatings: Flow Aid, Matting and Anti-Caking Functions
Silica Flatting Agent: Gloss Reduction Mechanism, Grades and Applications
Silica for Chromatography: Particle Size, Pore Size and Grade Selection
69. Qi G., Shi G., Wang S., Hu H., Zhang Z., Yin Q., Li Z., Hao L. A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxorubicin (DOX) and Glucose Oxidase (Gox) for Pancreatic Cancer Treatment. Int. J. Nanomed. 2023;18:7133-7147. doi: 10.2147/IJN.S436253. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
Toothpaste Grade Silica: Abrasive vs Thickening Silica, RDA Values and Specifications
Table 2.

Hydrophobic Silica Powder: Properties, Water Repellency and Industrial Uses

What is silica (SiO₂)?

Denka spherical silica

What is the difference between fumed silica and precipitated silica?

is silica soluble in water 57. Narayan R., Nayak U.Y., Raichur A.M., Garg S. Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances. Pharmaceutics. 2018;10:118. doi: 10.3390/pharmaceutics10030118. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]

What drives silica raw material prices?

diatomite Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].

Cite this article: Silica Raw Materials News. "How to Choose a Silica Supplier: Key Criteria, Certifications and Red Flags ." Published 2026-11-20 01:01:28. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.